75 related articles for article (PubMed ID: 37770872)
1. Duration and dosing of Proton Pump Inhibitors associated with high incidence of chronic kidney disease in population-based cohort.
Rodríguez-Poncelas A; Barceló MA; Saez M; Coll-de-Tuero G
PLoS One; 2018; 13(10):e0204231. PubMed ID: 30332411
[TBL] [Abstract][Full Text] [Related]
2. The association between proton pump inhibitors and hyperparathyroidism: a potential mechanism for increased fracture-results of a large observational cohort study.
Fitzpatrick D; Lannon R; Laird E; Ward M; Hoey L; Hughes CF; Strain JJ; Cunningham C; McNulty H; Molloy AM; McCarroll K
Osteoporos Int; 2023 Nov; 34(11):1917-1926. PubMed ID: 37530847
[TBL] [Abstract][Full Text] [Related]
3. Association of Proton Pump Inhibitor Use With Incident Dementia and Cognitive Decline in Older Adults: A Prospective Cohort Study.
Mehta RS; Kochar B; Zhou Z; Broder JC; Chung P; Yang K; Lockery J; Fravel M; Ryan J; Mahady S; Orchard SG; McNeil JJ; Murray A; Woods RL; Ernst ME; Chan AT
Gastroenterology; 2023 Sep; 165(3):564-572.e1. PubMed ID: 37315867
[TBL] [Abstract][Full Text] [Related]
4. Non-indicated initiation of proton pump inhibitor and risk of adverse outcomes in patients with underlying chronic kidney disease: a nationwide, retrospective, cohort study.
Kim SG; Cho JM; Han K; Joo KW; Lee S; Kim Y; Cho S; Huh H; Kim M; Kang E; Kim DK; Park S
BMJ Open; 2024 Jan; 14(1):e078032. PubMed ID: 38286693
[TBL] [Abstract][Full Text] [Related]
5. Proton Pump Inhibitors and CKD: The Evidence Builds.
Grams ME; Wilson FP
J Am Soc Nephrol; 2024 May; ():. PubMed ID: 38809613
[No Abstract] [Full Text] [Related]
6. Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis.
Wijarnpreecha K; Thongprayoon C; Chesdachai S; Panjawatanana P; Ungprasert P; Cheungpasitporn W
Dig Dis Sci; 2017 Oct; 62(10):2821-2827. PubMed ID: 28836158
[TBL] [Abstract][Full Text] [Related]
7. PPIs and kidney disease: from AIN to CKD.
Moledina DG; Perazella MA
J Nephrol; 2016 Oct; 29(5):611-6. PubMed ID: 27072818
[TBL] [Abstract][Full Text] [Related]
8. Kidney function decline associated with proton pump inhibitors: results from the ELSA-Brasil cohort.
Dos Santos AS; de Menezes ST; Silva IR; Oliveira WN; Pereira ML; Mill JG; Barreto SM; Figueiredo RC
BMC Nephrol; 2023 Sep; 24(1):285. PubMed ID: 37770872
[TBL] [Abstract][Full Text] [Related]
9. Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study.
Hart E; Dunn TE; Feuerstein S; Jacobs DM
Pharmacotherapy; 2019 Apr; 39(4):443-453. PubMed ID: 30779194
[TBL] [Abstract][Full Text] [Related]
10. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
[TBL] [Abstract][Full Text] [Related]
11. Lack of association between proton pump inhibitor use and decline in cognitive performance in the ELSA-Brasil cohort.
Dos Santos AS; de Menezes ST; Bensenor IM; Goulart AC; Barreto SM; Figueiredo RC
Eur J Clin Pharmacol; 2021 Nov; 77(11):1725-1735. PubMed ID: 34014336
[TBL] [Abstract][Full Text] [Related]
12. Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury.
Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
Kidney Int; 2017 Jun; 91(6):1482-1494. PubMed ID: 28237709
[TBL] [Abstract][Full Text] [Related]
13. Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease: The CKD-REIN cohort study.
Liabeuf S; Lambert O; Metzger M; Hamroun A; Laville M; Laville SM; Frimat L; Pecoits-Filho R; Fouque D; Massy ZA; Jacquelinet C; Stengel B;
Br J Clin Pharmacol; 2021 Jul; 87(7):2967-2976. PubMed ID: 33368448
[TBL] [Abstract][Full Text] [Related]
14. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease.
Katz PO; Dunbar KB; Schnoll-Sussman FH; Greer KB; Yadlapati R; Spechler SJ
Am J Gastroenterol; 2022 Jan; 117(1):27-56. PubMed ID: 34807007
[TBL] [Abstract][Full Text] [Related]
15. Differences between self-reported and laboratory measures of diabetes, chronic kidney disease, and hypercholesterolemia.
Pinheiro PC; Barros MBA; Szwarcwald CL; Machado ÍE; Malta DC
Cien Saude Colet; 2021 Apr; 26(4):1207-1219. PubMed ID: 33886751
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
